We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$115M
AUM Growth
-$677K
Cap. Flow
-$15.8M
Cap. Flow %
-13.74%
Top 10 Hldgs %
55.42%
Holding
157
New
40
Increased
38
Reduced
31
Closed
26

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$1.3M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$605K
3
NTES icon
NetEase
NTES
+$589K
4
CP icon
Canadian Pacific Kansas City
CP
+$531K
5
OTIC
Otonomy, Inc.
OTIC
+$432K

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$1.9M
2
VGR
Vector Group Ltd.
VGR
+$774K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$690K
4
SILC icon
Silicom
SILC
+$367K
5
MA icon
Mastercard
MA
+$361K

Sector Composition

Rank Sector Weight
1 Technology 6.64%
2 Consumer Discretionary 4.92%
3 Communication Services 4.55%
4 Healthcare 3.41%
5 Real Estate 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBR icon
101
CALL
Nabors Industries
NBR
$1.16B
$10K 0.01%
+234
New +$85.6K
IVC
102
PUT
DELISTED
Invacare Corporation
IVC
$9K 0.01%
40,100
+27,300
+213% +$390K
INSM icon
103
CALL
Insmed
INSM
$22.7B
$8K 0.01%
+27,800
New +$530K
TEVA icon
104
PUT
Teva Pharmaceuticals
TEVA
$36.2B
$8K 0.01%
+18,300
New +$412K
INTC icon
105
PUT
Intel
INTC
$462B
$7K 0.01%
45,200
+19,600
+77% +$697K
ARAV
106
PUT
DELISTED
Aravive, Inc. Common Stock
ARAV
$6K 0.01%
+50
New +$5.04K
NBR icon
107
PUT
Nabors Industries
NBR
$1.16B
$5K ﹤0.01%
+228
New +$83.4K
NXPI icon
108
PUT
NXP Semiconductors
NXPI
$67.6B
$4K ﹤0.01%
18,000
+2,500
+16% +$279K
SIOX
109
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$4K ﹤0.01%
20,313
+7,413
+57% +$1.25M
ZGNX
110
PUT
DELISTED
Zogenix, Inc.
ZGNX
$4K ﹤0.01%
193,700
+168,100
+657% +$2.28M
INSM icon
111
PUT
Insmed
INSM
$22.7B
$3K ﹤0.01%
46,500
+9,900
+27% +$189K
FNSR
112
PUT
DELISTED
Finisar Corp
FNSR
$3K ﹤0.01%
+3,000
New +$73.5K
VGR
113
PUT
DELISTED
Vector Group Ltd.
VGR
$2K ﹤0.01%
35,288
+5,907
+20% +$76.7K
PTCT icon
114
CALL
PTC Therapeutics
PTCT
$6.29B
$1K ﹤0.01%
+300
New +$5.87K
TEVA icon
115
CALL
Teva Pharmaceuticals
TEVA
$36.2B
$1K ﹤0.01%
+2,700
New +$60.8K
ARAV
116
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$1K ﹤0.01%
12,033
+8,366
+228% +$844K
ANET icon
117
Arista Networks
ANET
$215B
– –
-202,576
Closed -$1.9M
ANET icon
118
PUT
Arista Networks
ANET
$215B
– –
-20,800
Closed -$2K
CLF icon
119
Cleveland-Cliffs
CLF
$6.99B
– –
-26,600
Closed -$184K
DBRG icon
120
PUT
DigitalBridge
DBRG
$2.93B
– –
-3,550
Closed -$1K
DBVT
121
CALL
DBV Technologies
DBVT
$823M
– –
-2,890
Closed -$389K
HWM icon
122
PUT
Howmet Aerospace
HWM
$115B
– –
-33,252
Closed -$4K
LPCN icon
123
CALL
Lipocine
LPCN
$17.6M
– –
-1,424
Closed -$6K
MA icon
124
Mastercard
MA
$487B
– –
-2,970
Closed -$361K
MWA icon
125
Mueller Water Products
MWA
$3.94B
– –
-11,521
Closed -$135K
2 3 4
5
6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Worth Venture Partners held 157 positions worth $115M, down 0.58% from $116M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Worth Venture Partners withdrew a net $15.8M in Q3 2017, closing 26 positions and reducing 31 holdings. Its most notable exit was Arista Networks, an estimated $1.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Worth Venture Partners opened a new position in PTC Therapeutics worth $1.32M.

  • Worth Venture Partners's largest Q3 2017 buy was PTC Therapeutics: 66,196 shares worth $1.32M.
  • Worth Venture Partners added most to NetEase in Q3 2017, an estimated $589K increase.
  • Worth Venture Partners's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $690K.
  • Worth Venture Partners fully exited Arista Networks in Q3 2017, selling an estimated $1.9M.
  • Worth Venture Partners's ten largest holdings make up 55% of its $115M portfolio in Q3 2017.
  • Worth Venture Partners opened 40 new positions and closed 26 in Q3 2017.
  • Worth Venture Partners's portfolio value fell 0.58% quarter-over-quarter to $115M.

Based on Worth Venture Partners's 13F filing for Q3 2017, filed 7 Nov 2017.